Hold on to your seats, fintech fans! Neo, the consumer-focused wealth and asset management startup, just secured a jaw-dropping $19 million in funding — pushing its valuation to a staggering $686 million. That’s a mind-blowing 2.7X jump from its last funding round, and it’s sending shockwaves across India’s booming wealthtech scene.
Why Is Everyone Suddenly Obsessed with Neo?
Neo isn’t…
After revolutionizing India’s healthcare space with PharmEasy, the trio of Dharmil Sheth, Dhaval Shah, and Hardik Dedhia are back — this time aiming to transform the highly fragmented and unorganized interior design and architecture industry. Their new venture, All Home, is already making waves with a valuation of $120 million, following a fresh funding round led by prominent investors.
Enter…
Lendingkart Finance Reports Massive Loss in FY25: What Went Wrong?
Lendingkart Finance, the digital lending arm of the Temasek-backed Lendingkart Group, has hit a financial rough patch. For the financial year ending March 2025, the company reported a net loss of ₹288.3 crore—marking a dramatic turnaround from the ₹60 crore profit it enjoyed just a year ago.
The loss before tax ballooned to…
CRED’s Shocking Move: Raising $200 Million with a Massive Cut in Valuation—Here’s Why It’s Happening
CRED Is Looking to Raise $200 Million—But There’s a Big Twist
In a surprising turn of events, CRED, the Kunal Shah-led fintech unicorn, is looking to raise up to $200 million. But here’s the kicker: this new funding round will come with a significant drop in valuation.
You read that right. CRED, which was once valued at an eye-popping $6.4 billion during its Series F funding round in 2022…
PharmEasy, once a shining star in India’s healthtech industry with a $5.6 billion valuation, has seen a dramatic drop in its worth, now valued at just $456 million. This steep decline has come to light after investor Janus Henderson disclosed it had significantly reduced the value of its shares in PharmEasy. What caused this sharp drop, and what does the future hold for the online pharmacy?
Introduction: The Call for Change in India’s Tech Landscape
In a thought-provoking post on X (formerly Twitter), Sridhar Vembu, the CEO of Zoho, called on Indian tech companies to rethink their priorities. Vembu, who has built a successful business with Zoho, urged Indian firms to focus on building sustainable revenue rather than chasing inflated valuations. His words have sparked a significant…
Accel, the prominent global venture capital firm, is reportedly in advanced discussions to lead a funding round of $30 million to $40 million in Truemeds, an innovative Indian online pharmacy focused on making healthcare more accessible through affordable generic medications. According to multiple sources familiar with the negotiations, the proposed valuation for the six-year-old startup stands at…
At the Global Fintech Fest in Mumbai, Infosys co-founder and chairman Nandan Nilekani highlighted that startups leveraging India’s digital public infrastructure (DPI) are now valued at $100 billion. Nilekani emphasized that the development of Aadhar and the Unified Payments Interface (UPI) was designed to lay down foundational “rails” for private sector innovation.
“The estimated market…
